“Buprenorphine doesn't hold me”: Neurochemical afterlives of state violence and the struggle for meaning in addiction treatment

This paper analyzes two disparate experiences of buprenorphine, a medication for opioid addiction, in California. Within the context of the U.S. War on Drugs and after decades of criminalization, buprenorphine represents a shift toward outpatient medical treatment of opioid addiction, but it has been unequally distributed and experienced across geographic settings and populations. Drawing on my interlocutor's description of buprenorphine's "hold," I interrogate how buprenorphine's symbolic and pharmacological power to embrace, restrain, and otherwise "hold" people arises through its social context. "Holding" is a patient-driven epistemology, working metaphorically and neurochemically, illustrating raced, classed, and gendered positionalities that simultaneously express and constrain forms of agency and resistance in ideological struggles over the meanings of care in addiction treatment. Buprenorphine's "hold," or lack thereof, can be read as a neurochemical embodiment of state violence, revealing intensities of carceral forms of "care" and possibilities for transforming addiction treatment meanings.

Authors

Institutions

Publication Details

Journal
Medical Anthropology Quarterly
Published
2026-06-25
DOI
https://doi.org/10.1111/maq.70083
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

“Buprenorphine doesn't hold me”: Neurochemical afterlives of state violence and the struggle for meaning in addiction treatment

Lauren Textor
Medical Anthropology Quarterly
Opioid Use Disorder Treatment
article

“Buprenorphine doesn't hold me”: Neurochemical afterlives of state violence and the struggle for meaning in addiction treatment

Lauren Textor
article en

Abstract

This paper analyzes two disparate experiences of buprenorphine, a medication for opioid addiction, in California. Within the context of the U.S. War on Drugs and after decades of criminalization, buprenorphine represents a shift toward outpatient medical treatment of opioid addiction, but it has been unequally distributed and experienced across geographic settings and populations. Drawing on my interlocutor's description of buprenorphine's "hold," I interrogate how buprenorphine's symbolic and pharmacological power to embrace, restrain, and otherwise "hold" people arises through its social context. "Holding" is a patient-driven epistemology, working metaphorically and neurochemically, illustrating raced, classed, and gendered positionalities that simultaneously express and constrain forms of agency and resistance in ideological struggles over the meanings of care in addiction treatment. Buprenorphine's "hold," or lack thereof, can be read as a neurochemical embodiment of state violence, revealing intensities of carceral forms of "care" and possibilities for transforming addiction treatment meanings.

Medical Anthropology Quarterly
University of California, Los Angeles (US)
Gender equality
Openalex Percentile: Top 6%
Opioid Use Disorder Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.